The recent success of immunotherapy has demonstrated the utility of harnessing the immune response for treating cancer and autoimmune disease. Deep quantitative proteomics offers the ability to go beyond known immunological markers and identify novel pathways and proteins that are implicated in the response to immunotherapy.
Here are a few examples of how Biognosys has applied proteomics to address key questions in the immune response to aid in the understanding of disease and the development of novel therapeutics.